These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1564 related articles for article (PubMed ID: 19697349)

  • 21. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
    Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
    Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.
    Sumer H; Liu J; Malaver-Ortega LF; Lim ML; Khodadadi K; Verma PJ
    J Anim Sci; 2011 Sep; 89(9):2708-16. PubMed ID: 21478453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse induced pluripotent stem cells.
    Geoghegan E; Byrnes L
    Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cells.
    Zaehres H; Kim JB; Schöler HR
    Methods Enzymol; 2010; 476():309-25. PubMed ID: 20691874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
    Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
    Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel strategy to derive iPS cells from porcine fibroblasts.
    Ruan W; Han J; Li P; Cao S; An Y; Lim B; Li N
    Sci China Life Sci; 2011 Jun; 54(6):553-9. PubMed ID: 21706416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo differentiation of induced pluripotent stem cells into male germ cells.
    Cai H; Xia X; Wang L; Liu Y; He Z; Guo Q; Xu C
    Biochem Biophys Res Commun; 2013 Apr; 433(3):286-91. PubMed ID: 23524261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
    Qi H; Pei D
    Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
    [No Abstract]   [Full Text] [Related]  

  • 34. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
    Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
    J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of human induced pluripotent stem cells from cord blood cells.
    Nishishita N; Takenaka C; Fusaki N; Kawamata S
    J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts.
    Chen M; Chen Q; Sun X; Shen W; Liu B; Zhong X; Leng Y; Li C; Zhang W; Chai F; Huang B; Gao Q; Xiang AP; Zhuo Y; Ge J
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5970-8. PubMed ID: 20484577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human iPS cell derivation/reprogramming.
    Park IH; Daley GQ
    Curr Protoc Stem Cell Biol; 2009 Jan; Chapter 4():Unit 4A.1. PubMed ID: 19170021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
    Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.